Docoh
Loading...

Filter options loading...
Top filers
Top filing types
Recent filing years
S-1
EX-10
PCSA Processa Pharmaceuticals Inc
13 Nov 12
IPO registration
7:00pm
), and this Agreement is executed pursuant to, and is intended to further incentivize Optionee. All capitalized terms in this Agreement shall have
DEF 14A
PCSA Processa Pharmaceuticals Inc
22 Apr 21
Definitive proxy
2:00pm
, incentivize, and retain our executive talent. Further, our executive compensation program is based on market best practices to ensure that it is appropriately … years so that we can continue to incentivize and retain the key contributors to our business, as described in greater detail in this proposal. Amended
10-K
2020 FY
PCSA Processa Pharmaceuticals Inc
24 Mar 21
Annual report
8:00pm
of certain federal healthcare programs, incentivize manufacturers to lower the list price of their products and reduce the out-of-pocket costs of drug
10-K
2019 FY
PCSA Processa Pharmaceuticals Inc
5 Mar 20
Annual report
7:00pm
competition, increase the negotiating power of certain federal healthcare programs, incentivize manufacturers to lower the list price of their products
S-1/A
PCSA Processa Pharmaceuticals Inc
17 Jul 20
IPO registration (amended)
5:25pm
manufacturer competition, increase the negotiating power of certain federal healthcare programs, incentivize manufacturers to lower the list price
S-1
mzn 7k01849axnz2uwo
13 Dec 19
IPO registration
5:32pm
424B4
rucxozv9 05nb8u
5 Oct 20
Prospectus supplement with pricing info
4:16pm
S-1/A
16a13uyjyg
30 Sep 20
IPO registration (amended)
4:06pm
S-1/A
ljaagol9p1wzmsi
16 Sep 20
IPO registration (amended)
8:00pm
  • 1